MedTrace Logo

Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin

NCT04403334 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2020-05-27

No results posted yet for this study

Summary

Comparative safety study of intracameral levofloxacin versus moxifloxacin for postoperative infection prophylaxis

Conditions

  • Cataract Senile
  • Endophthalmitis
  • Antibiotic Side Effect
  • Safety Issues

Interventions

DRUG

Levofloxacin Ophthalmic

0.1 ml of unpreserved 0.5% levofloxacin

DRUG

Moxifloxacin Ophthalmic

0.1 ml of unpreserved 0.5% moxifloxacin

Sponsors & Collaborators

  • Peregrine Eye and Laser Institute

    lead OTHER

Principal Investigators

  • Harvey S Uy, MD · Peregrine Eye and Laser Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-02
Primary Completion
2018-04-28
Completion
2018-04-28

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04403334 on ClinicalTrials.gov